Climb Bio (NASDAQ:CLYM) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS
Climb Bio (NASDAQ:CLYM - Get Free Report) issued its earnings results on Thursday. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.06...